Literature DB >> 17116438

New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited.

Burke A Cunha1.   

Abstract

Nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline are antibiotics with proven effectiveness against selected pathogens. These antibiotics have not developed resistance over time. As "low-resistance potential antibiotics" that are effective against an increasing number of infections due to resistant gram-positive or gram-negative pathogens, these antimicrobials remain an important part of the antibiotic armamentarium. They will be used increasingly in the future, as highly resistant organisms continue to be important clinically and therapeutic options remain limited.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116438     DOI: 10.1016/j.mcna.2006.07.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  17 in total

1.  Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections.

Authors:  Burke A Cunha; Paul E Schoch; Jean R Hage
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

2.  Polymyxin B induces lysis of marine pseudoalteromonads.

Authors:  Mart Krupovic; Rimantas Daugelavicius; Dennis H Bamford
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

Review 3.  Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

Authors:  B A Cunha; J Baron; C B Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-17       Impact factor: 3.267

4.  Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis.

Authors:  Chenju Yi; Zhiyuan Zhang; Wei Wang; Caroline Zug; Hermann J Schluesener; Zhiren Zhang
Journal:  Neurochem Res       Date:  2011-06-08       Impact factor: 3.996

5.  Doxycycline-mediated inhibition of choroidal neovascularization.

Authors:  Sonia Samtani; Juan Amaral; Maria M Campos; Robert N Fariss; S Patricia Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-10       Impact factor: 4.799

6.  Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections.

Authors:  Ronald P Olson; Lizzie J Harrell; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

7.  Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3.

Authors:  Yuri Cho; Hyo Jin Son; Eun-Mee Kim; Ji Hyun Choi; Sung Tae Kim; In Jung Ji; Dong Hee Choi; Tong H Joh; Yoon Seong Kim; Onyou Hwang
Journal:  Neurotox Res       Date:  2009-07-07       Impact factor: 3.911

Review 8.  Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Authors:  Bradley J Gardiner; Andrew J Stewardson; Iain J Abbott; Anton Y Peleg
Journal:  Aust Prescr       Date:  2019-02-01

9.  Antimicrobial resistance among Escherichia coli that cause childhood community-acquired urinary tract infections in Northern Italy.

Authors:  Alessandra Caracciolo; Alberto Bettinelli; Claudio Bonato; Clementina Isimbaldi; Alessandro Tagliabue; Laura Longoni; Mario G Bianchetti
Journal:  Ital J Pediatr       Date:  2011-01-06       Impact factor: 2.638

10.  In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

Authors:  Luigi Principe; Silvia D'Arezzo; Alessandro Capone; Nicola Petrosillo; Paolo Visca
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-05-21       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.